In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice

Brain, Behavior, and Immunity

Volumn 22, Issue 6, 2008, Pages 850-860

  Fu, Cai Y ^a,b   Zhao, You L ^b   Dong, Li ^b   Chen, Qiang ^b   Ni, Jing M ^b   Wang, Rui ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b LANZHOU UNIVERSITY   (China)

Author keywords

A competitive antagonist at GABAA receptors; Antinociception; Human HK 1 and its truncated form h HK 1(4 11); Opioid receptors antagonists; SR140333 and SR48968

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANALGESIC AGENT; BETA FUNALTREXAMINE; BICUCULLINE; DELTA OPIATE RECEPTOR; HEMOKININ 1; HEMOKININ 1(4-11); MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; NALTRINDOLE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR ANTAGONIST; NOLPITANTIUM; NORBINALTORPHIMINE; OPIATE ANTAGONIST; SAREDUTANT; TACHYKININ;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; EXPERIMENTAL TEST; IN VIVO STUDY; MALE; MOUSE; NERVE CELL; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; BENZAMIDES; BICUCULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PIPERIDINES; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, OPIOID; TACHYKININS; TROPANES;

EID: 46049118236     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.12.010     Document Type: Article

References (46)

1. Bartolini A., Bartolini R., Biscini A., Giotti A., and Malmberg P. Investigations into baclofen analgesia: effect of naloxone, bicuculline, atropine and ergotamine. Br. J. Pharmacol. 72 (1981) 156-157
2. Bellucci F., Carini F., Catalani C., Cucchi P., Lecci A., Meini S., Patacchini R., Quartara L., Ricci R., Tramontana M., Giuliani S., and Maggi C.A. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br. J. Pharmacol. 135 (2002) 266-274
3. Berger A., and Paige C.J. Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study. J. Neuroimmunol. 164 (2005) 48-56
4. Cascieri M.A., Huang R.R., Fong T.M., Cheung A.H., Sadowski S., Ber E., and Strader C.D. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol. Pharmacol. 41 (1992) 1096-1099
5. Duffy R.A., Hedrick J.A., Randolph G., Morgan C.A., Cohen-Williams ME., Vassileva G., Lachowicz J.E., Laverty M., Maguire M., Shan L.S., and Gustafson E. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 45 (2003) 242-250
6. Endo D., Ikeda T., Ishida Y., Yoshioka D., and Nishimori T. Effect of intrathecal administration of hemokinin-1 on the withdrawal response to noxious thermal stimulation of the rat hind paw. Neurosci. Lett. 392 (2006) 114-117
7. Fong T.M., Yu H., and Strader C.D. Molecular basis for the species selectivity of the neurokin-1 receptor antagonist CP-96345. J. Biol. Chem. 267 (1992) 25668-25671
8. Frederickson R.C., Burgis V., Harrell C.E., and Edwards J.D. Dual actions of substance P on nociception: possible role of endogenous opioids. Science 199 (1978) 1359-1362
9. Fu C.Y., Kong Z.Q., Long Y., Chen Q., and Wang R. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: systemic study in anesthetized rats. Eur. J. Pharmacol. 572 (2007) 175-181
10. Fu C.Y., Tang X.L., Yang Q., Chen Q., and Wang R. Effects of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on the antinociceptive activity of pethidine administered at the peripheral and supraspinal level. Behav. Brain Res. 184 (2007) 39-46
11. Fu C.Y., Kong Z.Q., Wang K.R., Yang Q., Zhai K., Chen Q., and Wang R. Effects and mechanisms of supraspinal administration of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on nociception in mice. Brain Res. 1056 (2005) 51-58
12. Fu C.Y., Yang Q., Wang K.R., Kong Z.Q., Chen Q., and Wang R. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level. Behav. Brain Res. 170 (2006) 293-301
13. Guan J.S., Xu Z.Z., Gao H., He S.Q., Ma G.Q., Sun T., Wang L.H., Zhang Z.N., Lena I., Kitchen I., Elde R., Zimmer A., He C., Pei G., Bao L., and Zhang X. Interaction with vesicle luminal protachykinin regulates surface expression of δ-opioid receptors and opioid analgesia. Cell 122 (2005) 619-631
14. Hahm E.T., Lee J.J., Min B.I., and Cho Y.W. Opioid inhibition of GABAergic neurotransmission in mechanically isolated rat periaqueductal gray neurons. Neurosci. Res. 50 (2004) 343-354
15. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12 (1957) 12-15
16. Harrison S., and Geppetti P. Substance p. Int. J. Biochem. Cell Biol. 33 (2001) 555-576
17. Iadarola M.J., Tang J., Costa E., and Yang H.Y. Analgesic activity and release of [Met5]Enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo. Eur. J. Pharmacol. 121 (1986) 39-48
18. Ingi T., Kitajima Y., Minamitake Y., and Nakanishi S. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells. J. Pharmacol. Exp. Ther. 259 (1991) 968-975
19. Kendall D.A., Browner M., and Enna J. Comparison of the antinociceptive effect of γ-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J. Pharmacol. Exp. Ther. 220 (1982) 482-487
20. Kotani H., Hoshimaru M., Nawa H., and Nakanishi S. Structure and gene organization of bovine neuromedin K precursor. Proc. Natl. Acad. Sci. USA 83 (1986) 7074-7078
21. Kurtz M.M., Wang R., Clements M.K., Cascieri M.A., Austin C.P., Cunningham B.R., Chicchi G.G., and Liu Q. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296 (2002) 205-212
22. Long Y., Fu C.Y., Tian X.Z., Chen J., Han M., and Wang R. Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide. Eur. J. Pharmacol. 569 (2007) 119-125
23. Ma Q.P., and Bleasdale C. Modulation of brain stem monoamines and γ-aminobutyric acid by NK1 receptors in rats. Neuroreport 13 (2002) 1809-1812
24. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 26 (1995) 911-944
25. B receptors and antagonism by CGP35348, prevent bicuculline and picrotoxin-induced antinociception. Neuropharmacology 31 (1992) 783-791
26. Metwali A., Blum A.M., Elliott D.E., Setiawan T., and Weinstock J.V. Cutting edge: hemokinin has substance P-like function and expression in inflammation. J. Immunol. 172 (2004) 6528-6532
27. Morteau O., Lu B., Gerard C., and Gerard N.P. Hemokinin 1 is a full agonist at the substance P receptor. Nat. Immunol. 2 (2001) 1088
28. Naranjo J.R., Arnedo A., De Felipe M.C., and Del Rio J. Antinociceptive and Met-Enkephalin releasing effects of tachykinins and substance P fragments. Peptides 7 (1986) 419-423
29. Nelson D.A., Marriott I., and Bost K.L. Expression of hemokinin 1 mRNA by murine dendritic cells. J. Neuroimmunol. 155 (2004) 94-102
30. Page N.M. New challenges in the study of the mammalian tachykinins. Peptides 26 (2005) 1356-1368
31. Page N.M., Bell N.J., Gardiner S.M., Manyonda I.T., Brayley K.J., Strange P.G., and Lowry P.J. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc. Natl. Acad. Sci. USA 100 (2003) 6245-6250
32. Page N.M., Woods R.J., and Lowry P.J. A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul. Pept. 98 (2001) 97-104
33. Patacchini R., and Maggi C.A. Peripheral tachykinin receptors as targets for new drugs. Eur. J. Pharmacol. 429 (2001) 13-21
34. Pennefather J.N., Patak E., Ziccone S., Lilley A., Pinto F.M., Page N.M., Story M.E., Grover S., and Candenas M.L. Regulation of the stimulant actions of neurokinin A and human hemokinin-1 on the human uterus: a comparison with histamine. Biol. Reprod. 75 (2006) 334-341
35. Pintado C.O., Pinto F.M., Pennefather J.N., Hidalgo A., Baamonde A., Sanchez T., and Candenas M.L. A role for tachykinins in female mouse and rat reproductive function. Biol. Reprod. 69 (2003) 940-946
36. 1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 31 (1997) 537-563
37. 1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 32 (1998) 1-49
38. Sawynok J., and LaBella F.S. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology 21 (1982) 397-404
39. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol. Rev. 54 (2002) 285-322
40. Snijdelaar D.G., Dirksen R., Slappendel R., and Crul B.J. Substance P. Eur. J. Pain 4 (2000) 121-135
41. Somogyi P., Hodgson A.J., Chubb I.W., Penke B., and Erdei A. Antisera to gamma-aminobutyric acid. II. Immunocytochemical application to the central nervous system. J. Histochem. Cytochem. 33 (1985) 240-248
42. Stewart J.M., Getto C.J., Neldner K., Reeve E.B., Krivoy W.A., and Zimmermann E. Substance P and analgesia. Nature 262 (1976) 784-785
43. Tang J., Chou J., Yang H.Y., and Costa E. Substance P stimulates the release of Met5-enkephalin-Arg6-Phe7 and Met5-enkephalin from rat spinal cord. Neuropharmacology 22 (1983) 1147-1150
44. Zhang Y., Lu L., Furlonger C., Wu G.E., and Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1 (2000) 392-397
45. Zhang Y., and Paige C.J. T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 102 (2003) 2165-2172
46. Zorn S.H., and Enna S.J. GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. Life Sci. 37 (1985) 1901-1912